ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,110Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 315

$464K Total Retail Price of All Prescriptions

Rank: 82 out of 315

885 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 885 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 885 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 7,400 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 573 548 1 1
LISINOPRIL 529 489 2 3
AMLODIPINE BESYLATE 398 372 3 2
ATENOLOL 345 309 4 11
ATORVASTATIN CALCIUM 292 275 5 5
LOSARTAN POTASSIUM 260 244 6 4
METFORMIN HCL 231 217 7 7
ALLOPURINOL 189 168 8 14
METOPROLOL TARTRATE 183 178 9 18
PRAVASTATIN SODIUM 155 140 10 10
GLIPIZIDE 135 116 11 30
FUROSEMIDE 132 127 12 15
WARFARIN SODIUM 117 95 13 20
ALENDRONATE SODIUM 116 113 14 12
HYDROCHLOROTHIAZIDE 113 108 15 16
LEVOTHROID 110 91 16 61
K-TAB 107 98 17 101
LEVOTHYROXINE SODIUM 106 91 18 6
CLOPIDOGREL 104 102 19 25
PROAIR HFA 94 84 20 52
DOXYCYCLINE HYCLATE 93 85 21 141
INSULIN SYRINGE 92 73 22 79
PREDNISONE 86 78 23 41
HYDROCODONE-ACETAMINOPHEN 86 79 S3 23 19
TAMSULOSIN HCL 84 84 25 21
TERAZOSIN HCL 82 82 26 63
TOLAZAMIDE 79 77 10 27 281
NOVOLIN N 76 73 28 96
ZOLPIDEM TARTRATE 70 53 29 29
CARVEDILOL 69 59 30 22
TRIAMTERENE-HYDROCHLOROTHIAZID 67 61 31 140
VYTORIN 67 63 31 223
CITALOPRAM HBR 64 47 33 72
DIGOXIN 61 53 34 45
SERTRALINE HCL 54 46 35 100
OXYCODONE HCL 54 49 S2 35 57
TOLBUTAMIDE 54 53 10 35 156
IBUPROFEN 52 48 38 89
LIPITOR 51 49 39 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.